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Mitotic chromosome binding predicts transcription
factor properties in interphase
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Mammalian transcription factors (TFs) differ broadly in their nuclear mobility and sequence-
speciﬁc/non-speciﬁc DNA binding. How these properties affect their ability to occupy speciﬁc
genomic sites and modify the epigenetic landscape is unclear. The association of TFs with
mitotic chromosomes observed by ﬂuorescence microscopy is largely mediated by non-speciﬁc
DNA interactions and differs broadly between TFs. Here we combine quantitative measure-
ments of mitotic chromosome binding (MCB) of 501 TFs, TF mobility measurements by
ﬂuorescence recovery after photobleaching, single molecule imaging of DNA binding, and
mapping of TF binding and chromatin accessibility. TFs associating to mitotic chromosomes are
enriched in DNA-rich compartments in interphase and display slower mobility in interphase and
mitosis. Remarkably, MCB correlates with relative TF on-rates and genome-wide speciﬁc site
occupancy, but not with TF residence times. This suggests that non-speciﬁc DNA binding
properties of TFs regulate their search efﬁciency and occupancy of speciﬁc genomic sites.
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Transcription factors (TFs) regulate gene expression bybinding regulatory sequences of target genes. TF ability tooccupy speciﬁc genomic sites depends on their nuclear
concentration, their ability to search the genome, and the chro-
matin environment of their binding sites. How TFs maximize
search efﬁciency for speciﬁc sites is incompletely understood.
Pioneering theoretical work proposed that DNA-binding proteins
display substantial non-speciﬁc DNA interactions, which mod-
ulate TF search efﬁciency2. The length of the DNA sequence
ﬂanking the Lac operator was later shown to impact Lac
Repressor on-rate, suggesting that local non-speciﬁc TF-DNA
interactions increase search efﬁciency by one-dimensional diffu-
sion along DNA3. Experimental and computational modeling
studies thus converge on a TF search model that combines 3D
diffusion and facilitated diffusion, the latter resulting from local
1D search mediated by sliding along DNA, local jumps or hop-
ping, and transfer between genomically-distant but physically
close segments of DNA (intersegment transfer)4–9. Such local
search mechanisms strongly modulate search efﬁciency and
mainly depend on transient non-speciﬁc protein-DNA associa-
tion1–3,10,11 mediated by electrostatic interactions12–19. While
gene arrays20–23 and more recently single molecule imaging24,25
have allowed monitoring speciﬁc DNA-binding events dynamics,
non-speciﬁc DNA binding of most mammalian TFs remains
uncharacterized, and thus to which extent this property impacts
genome-wide occupancy of TFs is unknown.
A minority of TFs were shown to associate with mitotic
chromosomes26. These interactions can be identiﬁed by ChIP-seq
on mitotic cells and TF-mitotic chromosome co-localization
analysis by ﬂuorescence microscopy. While ChIP-seq essentially
identiﬁes sequence-speciﬁc DNA binding, ﬂuorescence micro-
scopy allows quantifying mitotic chromosome association inde-
pendently of enrichment on speciﬁc genomic sites26. Importantly,
immunoﬂuorescence protocols involving chemical ﬁxation cause
the artifactual eviction of chromatin-bound TFs27–30. In contrast,
live cell imaging of TFs fused to ﬂuorescent proteins bypass this
problem. Both non-speciﬁc and speciﬁc DNA binding of TFs to
mitotic chromosomes have been described. However, the often
small number of speciﬁcally-bound loci on mitotic chromo-
somes31–34, the mild or null sensitivity to alterations of speciﬁc
DNA binding properties31,35, and the absence of quantitative
relationship between mitotic ChIP-seq datasets and ﬂuorescence
microscopy33 suggest that co-localization of TFs with mitotic
chromosomes as observed by microscopy is largely due to non-
speciﬁc DNA interactions. Converging evidence from the litera-
ture further corroborates this view. SOX2 and FOXA1 strongly
associate with mitotic chromosomes31,32 and display high non-
speciﬁc afﬁnity for DNA in vitro36,37. In contrast, OCT4 displays
less visible association with mitotic chromosomes32 and has low
non-speciﬁc afﬁnity for DNA in vitro37. Finally, FOXA1 mutants
with decreased non-speciﬁc DNA afﬁnity but retaining their
speciﬁcity for the FOXA1 motif also display reduced mitotic
chromosome association31.
Many TFs binding to mitotic chromosomes have pioneer
properties31,34,38,39, i.e., they can bind and open condensed
chromatin regions. However, the existence of a common mole-
cular mechanism underlying mitotic chromosome binding and
pioneer activity remains uncertain.
Here we measure mitotic chromosome binding (MCB) of 501
mouse TFs in live mouse embryonic stem (ES) cells. We show
that MCB correlates with interphase TF properties such as sub-
nuclear localization, mobility, and with large differences in TF
ability to occupy speciﬁc genomic sites. We propose that the co-
localization of TFs with mitotic chromosomes is a proxy for TF
non-speciﬁc DNA binding properties, which regulate TF search
efﬁciency for their speciﬁc binding sites and thereby their
impact on chromatin accessibility.
Results
Large-scale assessment of TF binding to mitotic chromosomes.
To measure MCB for a large number of TFs, we constructed a
doxycycline (dox)-inducible lentiviral vector library of 757 mouse
TFs fused to a yellow ﬂuorescent protein (YPet) (Fig. 1a). This
library was used to generate a corresponding library of mouse
embryonic stem (ES) cell lines to quantify TF MCB by live cell
ﬂuorescence microscopy. Cells were seeded in 96-well plates and
treated with dox to induce expression of TF-YPet fusion proteins.
and the next day they were imaged by wide-ﬁeld ﬂuorescence
microscopy. We used a semi-automated pipeline to detect cells in
metaphase, allowing easy quantiﬁcation of MCB since chromo-
somes are most spatially conﬁned in this phase. Of note, we did
not observe obvious differences in TF co-localization with mitotic
chromosomes between prophase, metaphase and anaphase. We
used the Mitotic Bound Fraction (MBF) as a metric for mitotic
chromosome binding, deﬁned as the averaged YPet ﬂuorescence
intensity on metaphase chromosomes multiplied by the fraction
of cellular volume occupied by DNA (as measured by confocal
microscopy, see Methods), divided by the total YPet signal
(Fig. 1a). We then asked whether MBF values depend on over-
expression levels, in at least 19 individual cells for each of 21
different TFs spanning a broad range of MBF. We found no
consistent correlation between these two parameters (Supple-
mentary Fig. 1a), suggesting that the MBF is largely independent
of overexpression levels. We also measured the MBF of an
endogenously expressed TF and the MBF of its overexpressed
counterpart, using a homozygous SOX2-SNAP cell line40 and a
dox-inducible SOX2-SNAP cell line41. We only observed modest
differences between their MBF values (Supplementary Fig. 1b).
We then compared wide-ﬁeld ﬂuorescence measurements with
those performed by confocal microscopy, and found these to be
in very good agreement (Supplementary Fig. 1c-d, Supplementary
Table 1). In total 501 TFs yielded sufﬁciently strong ﬂuorescent
signals in metaphase to allow measuring their MBF, and for 94%
of these we could measure the MBF in at least 10 cells (see
Methods). We deﬁned three bins of TFs based on visual inspec-
tion of the YPet signal on metaphase chromosomes: depleted
(YPet signal lower than in the cytoplasm), intermediate (YPet
signal equal to that of the cytoplasm) or enriched (YPet signal
higher than in the cytoplasm), corresponding to MBFs <16.5%,
16.5–23% and >23%, respectively. Twenty-four percent of TFs fell
in the depleted bin, 54% in the intermediate bin, and 22% in the
enriched bin (Fig. 1b). Most TFs previously reported as enriched
on mitotic chromosomes and for which we could obtain MBF
values, such as FOXA131, GATA134, SOX227,32, ESRRB35,
HMGB229,31, and HMGN129, fell in the intermediate (ESRRB) or
enriched (all ﬁve other TFs) category (Supplementary Table 2),
suggesting that C-terminal YPet fusion does generally not perturb
MCB. We also measured the MBF of a subset of TFs in NIH-3T3
cells, yielding consistent results (Supplementary Fig. 1e-f, Sup-
plementary Table 3), suggesting that intrinsic TF properties are
major determinants of mitotic chromosome association. We next
compared our results with those obtained by a proteomics study
investigating chromatin-bound proteins over the cell cycle42.
Importantly, that study used a different cell type (a glioblastoma
cell line), species (human), and involved PFA cross-linking that
can lead to artifactual disruption of TF-mitotic chromosome
interactions27–30. Nevertheless, we found our results to globally
agree with theirs (Supplementary Fig. 1g). Furthermore, while in
contrast to the study by Ginno et al.42, our library contains TFs
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that are endogenously expressed in ES or NIH-3T3 cells but also
many that are not, we did not ﬁnd signiﬁcant differences in MBF
values between these two groups (Supplementary Fig. 1h). This
suggests that endogenous TF expression status does not strongly
impact its MBF.
Next, we clustered TFs according to their DNA binding
domains (DBD) and found that members of some TF families
(e.g., homeodomain or tryptophan cluster) were more likely to be
enriched on mitotic chromosomes (Fig. 1c). In contrast, C2H2
Zinc-ﬁnger TFs were underrepresented in the enriched category,
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in line with mitotic phosphorylation preventing their association
with DNA during M-phase43,44. However, the broad range of
MBF within each family indicates that DNA binding domain type
does not strictly govern the MBF (Fig. 1c), suggesting other TF
characteristics involved in regulating mitotic chromosome
association.
The MBF depends on electrostatic properties. We next used a
machine learning algorithm (see Methods) based on a lasso
regularized generalized linear model45 to uncover TF features that
could explain differences in MBF (Fig. 1d and Supplementary
Fig. 1i). We collected a large number of features from the amino
acid sequence of 401 different TFs (see Methods and Supple-
mentary Table 4) to ﬁnd those that are correlated with the MBF.
We ran the algorithm 500 times on the data to obtain parameters
used to predict the MBF of the remaining 100 TFs. The algorithm
selects variables allowing predicting the MBF, while coefﬁcients of
non-predictive parameters are set to zero. Similarly, coefﬁcients
of covariates that are correlated among them are set to zero to
select a reduced subset of predictive variables. We then kept only
parameters with a coefﬁcient >0 in at least 90% of the runs
(Fig. 1d). As expected, certain types of DBD, such as the tryp-
tophan cluster TF family and the C2HC Zinc ﬁngers were
moderately predictive of the MBF. The other parameters most
strongly correlated with the MBF were the fractions of polar
amino acids and disordered domains, and the absolute charge per
DBD (number of basic minus number of acidic residues), while
the fraction of aliphatic and hydrophobic amino acids was
negatively correlated with the MBF (Fig. 1d). We then compared
these parameters between the three different TF bins we deﬁned
above (Fig. 1b). Although broadly distributed in each bin, all of
them were signiﬁcantly different in TFs enriched on mitotic
chromosomes (Fig. 1e). The absolute charge per DBD was the
most distinctive parameter between TFs enriched on mitotic
chromosomes (dark blue) versus those that are not (medium and
light blue), suggesting that electrostatic interactions play an
important role in mitotic chromosome association of TFs.
TFs usually harbor one or several nuclear localization signals
(NLS), which often consist of a series of positively charged amino
acids. During mitosis, Ran guanine nucleotide exchange factor
(RCC1) associates with mitotic chromosomes, thereby maintain-
ing a GTP/GDP gradient between mitotic chromosomes and the
cytoplasm46. As NLS sequences were suggested to mediate MCB
through active transport27,28, we aimed to determine whether the
impact of positive charges could be confounded by active NLS-
mediated transport of TFs to mitotic chromosomes. To do so, we
engineered YPet fusions to either an NLS or an equivalent
number of positive charges not predicted to mediate nuclear
import. The addition of positive charges to the YPet protein was
sufﬁcient to increase its co-localization with mitotic chromo-
somes, independently of nuclear import (Supplementary Fig. 1j).
We also added ﬁve positively charged amino acids to the N-
terminus of four different TFs, and as expected these displayed an
increased MBF (Supplementary Fig. 1k). Taken together, these
results are in line with previous studies suggesting that (i) non-
speciﬁc DNA binding is essentially mediated by electrostatic
protein-DNA interactions, and (ii) non-speciﬁc DNA binding is
largely responsible for the co-localization of TFs with mitotic
chromosomes.
The MBF correlates with interphase TF-DNA co-localization.
Since mitotic chromosome association reﬂects general non-
speciﬁc DNA binding properties, we next asked whether the
MBF scales with TF-DNA co-localization in interphase. To
address this question, we used NIH-3T3 cells, which display easily
identiﬁable regions of varying chromatin densities. We stained
NIH-3T3 cells with Hoechst and classiﬁed the signal in three bins
using automatic image thresholding: (i) very dense, H3K9me3-
enriched heterochromatin regions (Fig. 2a); (ii) DNA-rich
regions; iii) DNA-poor regions (Fig. 2b, Methods). We then
generated 38 NIH-3T3 cell lines allowing dox-inducible expres-
sion of selected TF-YPet fusions spanning a broad range of MBF.
After overnight dox treatment and Hoechst staining, we per-
formed two-color confocal microscopy to measure YPet-Hoechst
signal co-localization (Fig. 2c). We observed a wide range of
spatial repartition of TFs, with some of them (e.g., Duxbl, Bhlhb8,
and Dlx6, Fig. 2c) highly enriched in heterochromatic regions.
The MBF and the co-localization of TFs with DNA in interphase
were positively correlated (Fig. 2d and Supplementary Table 5).
We then determined this correlation within the different sub-
nuclear regions we deﬁned, and found the MBF to be positively
correlated with enrichment in heterochromatin regions (Fig. 2e
and Supplementary Table 5) and to a lesser extent with enrich-
ment in DNA-rich regions (Fig. 2f and Supplementary Table 5).
In contrast, the MBF was strongly, inversely correlated with
enrichment in DNA-poor regions (Fig. 2g and Supplementary
Table 5). Thus, TFs with a high MBF tend to be excluded from
DNA-poor regions and are distributed mainly within hetero-
chromatic and DNA-rich regions in interphase, suggesting that
non-speciﬁc TF-DNA interactions also control interphase TF
localization.
The MBF correlates with mitotic and interphase TF mobility.
We reasoned that co-localization with DNA-rich regions result-
ing from transient TF-DNA interactions should decrease TF
mobility in the cell. To test this hypothesis, we performed
ﬂuorescence recovery after photobleaching (FRAP) experiments
in ES cells on 15 selected TFs with different MBF in mitotic and
interphase cells, as well as FRAP on interphase cells only for 3
TFs excluded from mitotic chromosomes (Fig. 3a, b, Supple-
mentary Table 6). We selected these 18 TFs based on their high
signal to noise ratio required for reliable FRAP measurements,
Fig. 1 Large scale quantiﬁcation of mitotic chromosome binding of TFs. a Experimental strategies for generating a lentiviral and ES cell TF-YPet expression
library and for quantifying their association to mitotic chromosomes. b Mitotic bound fraction of 501 transcription factors, ranked from lowest to highest
and grouped in three bins according to the color code described in the caption (for n values see Supplementary Table 2). Microscopy inset show
representative images of TF localization in metaphase for each category. Scale bar: 3 µm. Error bars: SEM. c Mitotic bound fraction of TFs with different
types of DNA binding domains. The color code is the same as in panel b. Boxes: intervals between the 25th and 75th percentile and median (horizontal
line). Error bars: 1.5-fold the interquartile range or the closest data point when no data point is outside this range. d Parameters recovered by machine
learning that impact the MBF and retained in the model for >90% of the runs (n= 500). Boxes: intervals between the 25th and 75th percentile and median
(horizontal line). Error bars: 1.5-fold the interquartile range or the closest data point when no data point is outside this range. e Violin plots of TF
distributions for the fraction of polar amino acids, fraction of disordered domains, number of basic residues minus the number of acidic residues, dispersion
of positive charges, and fraction of hydrophobic amino acids, grouped in the same categories as in panel b (nDepleted= 118, nIntermediate= 272, nEnriched= 111).
∗p-value<0.05; ∗∗p-value<0.01; ∗∗∗p-value<0.001; NS not signiﬁcant (Wilcoxon rank-sum test). P-values were obtained using a Wilcoxon rank-sum test
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and their coverage of a broad range of MBF. We then used half-
time (t1/2) of ﬂuorescence recovery as a metric of TF mobility.
Mitotic and interphase t1/2 of ﬂuorescence recovery displayed a
strong positive correlation (Fig. 3c and Supplementary Table 6),
and TF mobility was strongly correlated with the MBF (Fig. 3d,
e). These results suggest that intrinsic TF properties govern the
MBF and TF mobility in both interphase and mitosis.
TF size or off-rate do not explain differences in mobility. FRAP
recovery times depend on 3D diffusion, speciﬁc and non-speciﬁc
DNA binding47. Since mitotic chromosome association observed
by ﬂuorescence microscopy largely depends on non-speciﬁc TF-
DNA interactions and correlates with t1/2 of FRAP, we reasoned
that differences in TF mobility might be mainly due to differences
in non-speciﬁc DNA binding. However, since 3D diffusion and
speciﬁc DNA binding also inﬂuence t1/2 of ﬂuorescence recovery,
we ﬁrst asked whether differences in these parameters could
explain differences in TF mobility. According to the Stokes-
Einstein equation, diffusion scales inversely with the size of
molecules. Even though differences in TF radius are predicted to
be very small since they scale with the third root of their mass, we
assessed the correlation between TF-YPet molecular weight and
FRAP t1/2 recovery (Supplementary Fig. 2a, b and Supplementary
Table 6). These two parameters were negatively correlated and
thus do not explain differences in TF mobility. To test whether
TFs quantitatively differ in their association with speciﬁc DNA
sites, we determined the immobile fraction, which corresponds to
the fraction of molecules that do not exchange over the time
course of FRAP experiments. The immobile fractions in inter-
phase and mitosis were well correlated with the mitotic bound
fraction (Fig. 3f, g), suggesting that TFs with a high MBF tend to
have a higher fraction of long binding events.
We then performed single molecule (SM) imaging of TFs in
live cells to monitor speciﬁc DNA binding events. This approach
allows comparing frequencies of speciﬁc DNA-binding events
between TFs at a given TF nuclear concentration, thus providing
a relative measure of TF on-rates. Furthermore, SM imaging
allows determining differences in TF residence times on speciﬁc
DNA sites. We generated 9 NIH-3T3 cell lines allowing dox-
inducible expression of TFs C-terminally fused to a HaloTag and
induced TF expression with low doses of dox shortly before
performing SM imaging in interphase cells, using highly inclined
and laminated optical sheet (HILO) microscopy24 (see Methods).
Single molecules were registered as bound to chromatin when
they were conﬁned for several frames inside a speciﬁed region
(see Methods). We then associated these binding events with
areas of bright, intermediate or dark Hoechst staining intensity
(Supplementary Fig. 3a and Supplementary Table 7), similarly as
for confocal measurements of TF nuclear distribution (see Fig. 2a,
b). In order to compare different TFs, we calculated the ratio of
DNA-binding events divided by the total number of detected
molecules, the area of the corresponding intensity class and the
recording time (Eq. 7 in Methods). This ratio provides a
frequency of DNA binding events. We referred to this frequency
for binding events lasting >1 s as the pseudo on-rate (ψon-rate
hereafter). We approximated the residence time of a TF with the
average time a molecule spent bound to DNA (Equation 8 in
Methods). FRAP t1/2 recovery times in interphase and mitosis
were correlated with interphase TF ψon-rates (Fig. 3h, i,
Supplementary Tables 6 and 7). In contrast, FRAP recovery
times were not correlated with relative interphase residence times
(Fig. 3j, k, Supplementary Tables 6 and 7). This suggests that
while differences in TF ψon-rates could contribute to differences
in TF mobility, differences in 3D diffusion or residence times on
speciﬁc DNA sites do not. This is also in line with non-speciﬁc
DNA binding contributing to differences in TF mobility and
search efﬁciency, thereby impacting TF ψon-rates on speciﬁc
sites.
TF occupancy correlates with ψon-rates but not off-rates. We
next aimed to determine the genome-wide TF occupancy at
speciﬁc sites for 21 TFs spanning a broad range of MBF, and we
also included two FOXA1 mutants that have reduced electrostatic
interactions with DNA, decreasing non-speciﬁc DNA binding
activity without altering their speciﬁcity for the FOXA1 DNA
motif31. As expected, FOXA1 mutants displayed a lower MBF
than wild-type FOXA131 (Supplementary Fig. 3b). For each TF,
we generated an NIH-3T3 cell line allowing their dox-inducible
expression with three HA tags fused to their C-terminus. We
veriﬁed that different TFs were expressed at roughly comparable
levels upon dox induction (Supplementary Fig. 3c, Supplementary
Table 8), allowing ChIP-seq measurements to provide relative
measurements of genome occupancy within a given TF con-
centration range. We then performed ChIP-seq using the same
anti-HA antibody for all TFs and used peak calling to determine
the number of speciﬁcally bound sites. Remarkably, for the 8 TFs
for which we obtained both ChIP-seq and single molecule mea-
surements, TF ψon-rates were strongly correlated with the
number of ChIP-seq peaks (Fig. 4a, Supplementary Fig. 3d-f,
Supplementary Tables 7 and 8). The offset of the linear ﬁt sug-
gests that a fraction of long-lived SM events is not detected by
ChIP-seq. As previously reported, these can result from long-
lived, non-speciﬁc DNA binding events or indirect TF-DNA
interactions23. In contrast, the number of ChIP-seq peaks was not
correlated with TF relative residence times (Fig. 4b, Supplemen-
tary Tables 7 and 8). This suggests that the differences in genome-
wide occupancy of TFs we observed are mainly due to differences
in their association rate but not to longer residence times on
speciﬁc DNA sites.
The MBF correlates with genome-wide TF occupancy. We used
the ChIP-seq data to compare relative TF occupancy of speciﬁc
sites in the genome with their MBF. We ﬁrst determined the
number of ChIP-seq peaks obtained for the 21 TFs, the two
FOXA1 mutants, with two biological replicates for OCT4, SOX2,
FOXA1, and BHLHB8 to estimate variability in recovering ChIP-
seq peaks. Remarkably, the MBF and the number of ChIP-seq
peaks were strongly correlated, with differences in ChIP-seq peak
numbers ranging over three orders of magnitude (Fig. 4c, d and
Supplementary Table 8). This correlation was robust to different
q-value thresholds (Supplementary Fig. 4a), peak calling algo-
rithms (Supplementary Fig. 4b), and downsampling to equalize
the number of reads for each TF (Supplementary Fig. 4c). Very
similar results were obtained when using the fraction of ChIP-seq
reads in peaks as another metric for TF occupancy (Supple-
mentary Fig. 4d and Supplementary Table 8), indicating that
differences in ChIP-seq peak amplitude are small compared to
differences in peak numbers. According to the law of mass action,
the rate of formation of a TF-DNA complex scales linearly with
its concentration, and therefore the six-fold range in TF expres-
sion level (Supplementary Fig. 3c) is unlikely to account for the
very large differences in ChIP-seq peak numbers we observed.
This relationship was also independent of the presence or absence
of endogenous expression of these TFs in NIH-3T3 cells (Fig. 4d
and Supplementary Table 8).
We then wondered why some TFs reported to display a high
number of ChIP-seq peaks when expressed in their endogenous
context displayed orders of magnitude fewer peaks in NIH-3T3
cells. While this may partly be due to differences in TF
concentrations, antibodies used, and ChIP-seq protocols, we
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reasoned that in some cases differences in binding partners could
also explain this discrepancy. In particular, OCT4 displayed two
orders of magnitude fewer ChIP-seq peaks in NIH-3T3 as
compared to ES cells48. As SOX2 and OCT4 form heterodimers,
and SOX2 can recruit OCT4 to DNA49,50, OCT4 may have a low
intrinsic ability to ﬁnd its target sites in the absence of a
heterodimeric partner. To test this hypothesis, we co-expressed a
YPet-SOX2 fusion protein with OCT4-HA in NIH-3T3 and
performed ChIP-seq against OCT4. While co-expression of YPet-
SOX2 did not alter the expression level of OCT4-HA (Supple-
mentary Fig. 4e), the number of peaks (Supplementary Fig. 4f)
and fraction of reads in peaks strongly increased (Supplementary
Fig. 4g) of OCT4-HA, suggesting that SOX2 drives OCT4 DNA
binding in NIH-3T3 cells.
The MBF scales with TF search efﬁciency for speciﬁc sites. The
number of sites bound by each TF may also depend on the
number of speciﬁc sites available in the genome. We thus
quantiﬁed the number of occurrences of the most highly enriched
(top) motif for the bound sites of each TF (see Supplementary
Table 9 and Methods). We then quantiﬁed the fraction of each
top motif that is occupied by its respective TF by dividing the
number of ChIP-seq peaks containing the top motif (Supple-
mentary Tables 8 and 9) by the total number of its occurrences in
the genome (fraction of occupied motifs or FOM). In addition, we
performed ATAC-seq on NIH-3T3 cells to map accessible
chromatin regions, allowing to calculate the FOM in open
chromatin regions. The FOM in both the whole (Fig. 4e) and
accessible genome (Supplementary Fig. 4h) strongly correlated
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with the MBF (Supplementary Table 8), suggesting large differ-
ences in TF ability to ﬁnd their speciﬁc sites, independently of the
number of sites present in the whole genome or within accessible
chromatin regions. Notably, some TFs were not enriched for their
known consensus motif from the literature but rather for motifs
annotated to other factors. This is not unexpected since TF
binding proﬁles are often context-dependent51,52, and motif
enrichment can also be due to indirect binding or the presence of
a motif in proximity of a true binding site. To exclude the pos-
sibility that our correlation is biased by indirect binding or
incorrect motif identiﬁcation, we analyzed the FOM at known
consensus sites for all factors signiﬁcantly enriched for a motif
annotated to the factor itself or a closely related protein (e.g., the
SOX3 motif for SOX2 and SOX15, see Supplementary Table 9
and Methods) and found this metric to also positively correlate
with the MBF (Supplementary Fig. 4i, j and Supplementary
Table 8). Therefore, our data suggests that the MBF is of strong
predictive value for the ability of TFs to occupy their speciﬁc sites
in the genome at a given TF concentration.
MCB does not predict pioneer activity. We then asked whether
the MBF is predictive of TF ability to modify chromatin acces-
sibility at their binding sites. Since pioneer TFs are suggested to
be more capable of targeting closed chromatin regions than non-
pioneer TFs53, we ﬁrst determined if the MBF was correlated with
a higher propensity to bind closed chromatin regions. We found
no correlation between the MBF and the fraction of TF ChIP-seq
peaks in closed chromatin (Fig. 5a and Supplementary Table 8),
and a weak positive correlation between the MBF and the FOM in
closed chromatin (Supplementary Fig. 5a). We then selected 13
TFs that are not endogenously expressed in NIH-3T3 cells based
on a published RNA-seq dataset54 to interrogate their ability to
modify chromatin accessibility. For each TF, we performed two
biological replicates of ATAC-seq after 48 h of dox induction in
the respective NIH-3T3 cell line (Fig. 5b and Supplementary
Fig. 5b). We counted the number of ATAC-seq reads in regions
bound by each TF in the control cell line and each overexpression
cell line and used edgeR and limma to call regions signiﬁcantly
(p < 0.05) either more or less accessible following overexpression
of the TF (see Methods). Overall, the number of regions with
changed accessibility coinciding with TF ChIP-seq peaks corre-
lated with the number of TF ChIP-seq peaks (Fig. 5c and Sup-
plementary Table 10). Of note, these regions displayed either
signiﬁcantly increased (Supplementary Fig. 5c) or decreased
(Supplementary Fig. 5d) accessibility, and both correlated with
the number of TF ChIP-seq peaks. As expected, a large number of
genomic sites to which known pioneer TFs such as SOX2 and
FOXA1 bound displayed changes in chromatin accessibility
(Fig. 5c, Supplementary Fig. 5b, and Supplementary Table 10).
The impact of TFs on both opening and closing chromatin can be
explained by the fact that many of these TFs were reported to
function as both activators and repressors48,55–60. Importantly,
these correlations were maintained when analyzing the same
regions for all TFs (deﬁned as all regions with an ATAC-seq peak
in at least one sample, see Methods) (Supplementary Fig. 5e-g).
To determine the intrinsic ability of each TF to modify chromatin
accessibility, we quantiﬁed the fraction of sites bound by each TF
that displayed signiﬁcant increase or decrease in chromatin
accessibility. Neither of them was correlated with the MBF
(Fig. 5d-e and Supplementary Table 10), suggesting that TFs with
a high MBF are not more potent on average in altering chromatin
accessibility. Therefore, a high MBF is not a signature for an
intrinsically higher propensity to alter chromatin accessibility.
Discussion
Recent studies have shown that TFs binding to mitotic chromo-
somes are rather common26,61, and these were proposed to play a
role in cell fate maintenance by controlling gene reactivation early
during mitotic exit31,34,39,62. Furthermore, the presence of SOX2
and OCT4 at the M-G1 transition was shown to be required for
their role in regulating ES cell fate decisions32,63. However, the
molecular mechanisms underlying MCB are largely unknown and
this property remains uncharacterized for the vast majority of
TFs. Here we measured MCB of 501 TFs and found over 100 to
be enriched on mitotic chromosomes. Our study thus provides a
large database of TFs to be mined for their potential role in cell
fate maintenance during cell division.
MCB as observed by ﬂuorescence microscopy is distinct from
the notion of mitotic bookmarking, which implies TF binding to
speciﬁc sites during mitosis. However, all mitotic bookmarking
TFs described so far are also decorating mitotic chromosomes as
assessed by ﬂuorescence microscopy27,31,32,34,35,62,63. Here we
show that TFs with a high MBF have a higher immobile fraction
on mitotic chromosomes, raising the possibility that these also
display a higher occupancy of speciﬁc sites during mitosis.
However, mitotic ChIP-seq results obtained by different labora-
tories show little agreement32,33,63, and the scarcity of data on
TFs displaying poor co-localization with mitotic chromosomes by
ﬂuorescence microscopy does not allow to draw clear conclusions
on the link between these two properties.
While our data indicate that the type of DNA binding domain
and electrostatic characteristics of TFs impact MCB of TFs, the in
silico determination of these properties based on TF amino acid
sequence was not sufﬁcient to accurately predict the MBF.
Therefore, measuring other parameters such as post-translational
modiﬁcations and three-dimensional structures of TF-DNA con-
tact interfaces is arguably required to improve MBF prediction.
We found that quantitative measurements of MCB are well
correlated to other TF properties. First, differences in the MBF
scaled inversely with TF mobility in both interphase and mitosis.
This can be explained by differences in non-speciﬁc DNA binding
properties, which drive mitotic chromosome association and
decrease TF mobility in the nucleus. Second, less mobile TFs
displayed higher ψon-rates, suggesting that non-speciﬁc DNA
association increases TF efﬁciency to search for target sites
through facilitated diffusion. This is also corroborated by the high
and low genome occupancy of TFs (SOX2 or FOXA1 versus
OCT4) with high and low non-speciﬁc DNA binding activity
in vitro, respectively37. Third, TFs differed broadly in their ability
to occupy speciﬁc sites in the genome during interphase, which
scaled with their MCB, even though these two measurements
were performed in different cell types. Since most TFs we studied
are not endogenously expressed in NIH-3T3 cells, they are likely
to depend essentially on their intrinsic ability to ﬁnd their speciﬁc
sites in the genome rather than on the cooperativity with other
TFs. Importantly, here we aimed to determine the intrinsic ability
of TFs to bind to their sites within a given concentration range.
Thus, optimization of TF expression levels in their physiological
context may further allow ﬁne-tuning their genome occupancy.
Interestingly, we found that OCT4 occupancy can be dramatically
increased by co-expression of SOX2, and we had reported that
SOX2 expression increases mitotic chromosome association of
OCT432. Therefore, it is possible that some TFs depend on
cooperativity with other DNA-binding proteins to mediate or
enhance MCB and search for speciﬁc binding sites.
Finally, our data also sheds light on the proposed link between
MCB and impact on chromatin accessibility. The MBF could
predict neither preferential binding to closed chromatin nor the
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inherent ability to modulate chromatin accessibility. However, the
higher number of speciﬁc binding sites of TFs with a high MBF
correlated with an increased absolute number of bound sites in
closed chromatin regions, as well as a broader impact on chro-
matin accessibility. Therefore, the on-average higher impact on
chromatin accessibility of TFs with a high MBF is mediated by
their enhanced ability to occupy speciﬁc sites rather than an
intrinsically higher ability to alter chromatin accessibility at target
sites.
In summary, our ﬁndings converge on a model in which non-
speciﬁc DNA binding properties play a central role in deter-
mining TF association to mitotic chromosomes and interphase
DNA. We propose that non-speciﬁc DNA binding governs TF
search efﬁciency for speciﬁc binding sites and thereby has a
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modest impact on TF ability to alter the chromatin accessibility
landscape (Fig. 6). Future studies should allow further under-
standing the molecular basis of differential non-speciﬁc DNA
binding activity and how this allows to optimize chromatin
scanning to ﬁnd target sites in the genome.
Methods
Cell lines and culture. The E14 mouse embryonic stem (ES) cell line (provided by
Didier Trono, EPFL) was used for all experiments involving ES cells. Cells were
routinely cultured at 37 °C and 5% CO2 in GMEM (Sigma-Aldrich, #G5154),
supplemented with 10% ES cell-qualiﬁed fetal bovine serum (ThermoFisher,
#16141079), 2 mM sodium pyruvate (Sigma-Aldrich, #113–24–6), 1% non-
essential amino acids (ThermoFisher, #11140035), 1% penicillin/streptomycin
(BioConcept, #4–01F00H), 2 mM L-glutamine (ThermoFisher, #25030–024),
100 μM 2-mercaptoethanol (Sigma-Aldrich, #63689–25ML-F), leukemia inhibitory
factor (LIF, concentration not determined, produced by transient transfection of
HEK-293T cells and tested for its potential to maintain pluripotency), 3 μM GSK-3
Inhibitor XVI (Merck Millipore, #361559) and 0.8 μM PD184352 (Sigma-Aldrich,
#PZ0181). Cells were grown on 100 mm cell culture dishes coated with 0.1%
gelatin, up to conﬂuences of about 70% and split 1:8 to 1:10 every 2–3 days upon
trypsinization.
NIH-3T3 cells (provided by Ueli Schibler, University of Geneva) and HEK
293T cells (ATCC) were routinely cultured at 37 °C and 5% CO2 in DMEM
(ThermoFisher, #41966029), supplemented with 10% fetal bovine serum
(ThermoFisher, #10270106) and 1% penicillin/streptomycin (BioConcept,
#4–01F00H). Cells were grown in 100 mm cell culture dishes up to a conﬂuence of
90% and split 1:6 every 3–4 days.
For single molecule imaging experiments, we cultured stable cell lines of
NIH3T3 cells with different TFs in DMEM supplemented with 10% FBS
(ThermoFisher, #10270106), 1% Sodium Pyruvate (Sigma-Aldrich, #113–24–6), 1%
GlutaMax (ThermoFisher, #35050061), 5 µg ml−1 Blasticidin, 2 µg/ml−1
Puromycin and 1% Penicillin-Streptomycin.
DNA constructs. A pENTR library containing the coding sequences of 750 mouse
transcription factors (TFs) without STOP codon64 was recombined in the
doxycycline-inducible expression vector described in ref. 32, (hereafter referred as
to pLVTRE3G-GW-HA/YPet). This vector allows for dox-inducible expression of
each TF fused either to a YPet (a yellow ﬂuorescent protein) or to three HA tags,
depending on the presence or absence of Cre recombinase, respectively. Addi-
tionally, the coding sequences of Gbx2, Klf2, Klf4, Klf5, Nanog, Tcf3, and Sox17
were added to the library by PCR ampliﬁcation from cDNA (primers in Supple-
mentary Table 11) extracted from either ES cells maintained in the pluripotent
state, or from ES cells differentiated for four days by removal of LIF and 2i. The
PCR amplicons were then inserted in the pDONR221 by BP-Gateway recombi-
nation (ThermoFisher) and veriﬁed by Sanger sequencing. The pENTR library was
then recombined into pLVTRE3G-GW-HA/YPet. The resulting lentiviral vector
library was used to generate a corresponding ES library for the large-scale quan-
tiﬁcation of TF binding to mitotic chromosomes and for ﬂuorescence recovery after
photobleaching (FRAP) experiments. In the cases of Sox15-YPet and Hoxd10-
YPet, the corresponding E14 cell lines did not yield high enough ﬂuorescence
intensity signals to perform FRAP experiments. To circumvent this issue, the
coding sequences of Sox15-YPet and Hoxd10-YPet were inserted into the
pLVTRE3GMCS backbone32, which allowed obtaining higher expression levels.
This was achieved by removing the Oct4 coding sequence from the pLVTRE3G-
Oct4-YPet plasmid32 using SalI and AscI digestion. The coding sequences of Sox15
and Hoxd10 were then PCR-ampliﬁed with primers ﬂanked with SalI and AscI
sites, digested with these enzymes, and ligated to SalI/AscI-cut pLVTRE3G-Oct4-
YPet.
The two FoxA1 non-speciﬁc DNA-binding mutants36 were generated by site-
directed mutagenesis before recombination in the pLVTRE3G-GW-HA/YPet, by
PCR (primers in Supplementary Table 11) on the FoxA1 pENTR vector.
The constructs for Halo-tagged TFs were generated using restriction cloning, by
digesting the pLVTRE3G-GW-HA/YPet with NdeI and AscI to replace the loxP-
3xHA-2xSTOP-LoxP-YPet with a NdeI and AscI-cut PCR product of the Halo-Tag
coding sequence ﬂanked by NdeI and AscI restriction sites. The selected TFs were
then shuttled from the pENTR library into the pLV-TRE3G-GW-Halo by LR-
Gateway recombination (ThermoFisher).
The YPet-NLS and YPet-NLS-mutant constructs were generated by
ampliﬁcation of YPet coding sequence from pLVTRE3G-GW-HA/YPet (primers in
Supplementary Table 11) to generate the fusion with four different peptides, all
bearing ﬁve positively charged amino-acids.
The PCR products were inserted in the pLVTRE3GMCS backbone (Deluz et al.,
2016) by restriction cloning using SalI and NdeI restriction sites.
The TFs fused to 5 arginine residues were generated by PCR ampliﬁcation
(primers in Supplementary Table 11) of the TF ORF from the corresponding
pENTR vectors.
The PCR products were transferred into the pENTR vector by BP-Gateway
recombination (ThermoFisher) followed by LR-Gateway recombination
(ThermoFisher) into the pLV-TRE3G-GW-HA/YPet.
Lentivector production and stable cell line generation. For quantiﬁcation of
mitotic chromosome binding of TFs, lentiviral vector production was carried out
by transfection of HEK 293T (cells (ATCC) seeded in 96-well plates with the
envelope (PAX2) and packaging (MD2G) constructs together with the lentiviral
vector of interest, using the X-tremeGENE 9 DNA Transfection Reagent (Roche,
#6365779001). Target E14 cells were engineered to constitutively express rtTA3G-
IRES-blasticidin, H2B-mCherry (Addgene, #21217) and Cre recombinase, referred
as to E14 ICC for Inducible H2B-mCherry Cre and described in Deluz et al., 2016.
E14 ICC cells were then used to generate 757 sub-cell lines (among which we were
able to grow 753) allowing dox-inducible expression of each transcription factor.
To do so, 4000 cells were seeded in 96-well plates and transduced on two con-
secutive days with 100 μl of non-concentrated lentiviral vector particles ﬁltered on
MultiScreenHTS 0.45 µm ﬁltering plates (Millipore, MSHVS4510). The same
transduction protocol was applied to NIH-3T3 ICC cells for quantiﬁcation of the
mitotic bound fraction (MBF) and TF-Hoechst co-localization experiments. Cell
lines allowing dox-inducible expression of TF fusions to Halo-Tag for single
molecule microscopy, as well as TF fusions to HA tags for ChIP-seq and ATAC-seq
experiments were generated by transduction of NIH-3T3 cells constitutively
expressing rtTA3G-IRES-blasticidin only.
ES cell lines used for FRAP experiments were generated by transduction of E14
ICC cells with concentrated lentiviral particles generated by calcium phosphate
transfection of HEK 293T cells. For all cell lines, selection of transduced cells was
performed by addition of the respective antibiotics 48 h after transduction, and
antibiotics were maintained in the cell culture medium throughout passaging. For
blasticidin selection, we used 8 µg ml−1 (E14 cells) or 5 µg ml−1 (NIH-3T3 cells);
for puromycin selection, we used 2 µg ml−1 (all cell lines).
To compare the MBF of endogenously and exogenously expressed SOX2-SNAP
fusion proteins (Supplementary Fig. 1b), we used the SOX2-SNAP homozygous
knock-in33 and SOX2-SNAP inducible cell lines65.
Live imaging of TFs and MBF quantiﬁcation. One day before imaging, cells were
seeded in black-walled 96-well plates that were either uncoated (NIH-3T3 cells) or
coated with E-Cadherin (R&D systems, #748-EC-050) as previously described66, and
transgene expression was induced with dox (Sigma-Aldrich, #D9891, 500 ng ml−1).
Prior to ES cell imaging, the medium was replaced by E14 imaging medium
High MBF Low MBF
• Low mobility
• High on-rate
• High search efficiency 
• High mobility
• Low on-rate
• Low search efficiency
High non-specific binding Low non-specific binding
High genome occupancy Low genome occupancy
Modulation of chromatin
accessibility
Pioneer activity
Fig. 6Mitotic chromosome binding predicts TF properties in interphase We
propose that the MBF allows to predict TF non-speciﬁc DNA binding, which
regulates TF mobility, on-rate and search efﬁciency, thus inﬂuencing
genome occupancy. Modulation of chromatin accessibility at bound sites
depends on genome-wide occupancy but even more so on pioneer activity
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(FluoroBrite DMEM (ThermoFisher, #A18967–01) supplemented with 10% ES cell-
qualiﬁed fetal bovine serum (ThermoFisher, #16141079), 2 mM sodium pyruvate
(Sigma-Aldrich, #113–24–6), 1% non-essential amino acids (ThermoFisher,
#11140035), 1% penicillin/streptomycin (BioConcept, #4–01F00H), 2 mM L-
glutamine (ThermoFisher, #25030–024), 100 μM 2-mercaptoethanol (Sigma-Aldrich,
#63689–25ML-F), LIF, 3 μM GSK-3 Inhibitor XVI (Merck Millipore, #361559) and
0.8 μM PD18435 (Sigma-Aldrich, #PZ0181)). Prior to NIH-3T3 cell imaging, the
medium was replaced by NIH-3T3 imaging medium (FluoroBrite DMEM supple-
mented with 10% FBS (ThermoFisher, #10270106) and 1 % penicillin/streptomycin).
Live ﬂuorescence imaging was performed at the Biomolecular Screening Facility of
EPFL on an IN Cell Analyzer 2200 apparatus (GE healthcare) with controlled
atmosphere (5% CO2) and temperature (37 °C) and a ×20 magniﬁcation objective,
using the YFP ﬂuorescence channel for YPet detection, and the TexasRed ﬂuorescence
channel for mCherry detection.
For E14 cells, identiﬁcation of mitotic cells and quantiﬁcation of the mitotic bound
fraction (MBF) were performed using a semi-automated custom pipeline on the
CellProﬁler software. Brieﬂy, cells in metaphase were automatically discriminated
from non-synchronized cells based on shape parameters, and validated by the user.
For each conﬁrmed metaphase cell, the selected area was adjusted to precisely deﬁne
the region containing metaphase chromosomes. This region was then blown-up by 5
pixels and subtracted from a 21 pixel circle drawn around the cell to deﬁne the
cytoplasmic region. The YPet ﬂuorescence signal was quantiﬁed in both regions. For
NIH-3T3 cells, regions in the cytoplasm and on the chromosomes were deﬁned by
visual inspection. For both cell lines, the MBF was calculated as:
MBF ¼ Schrom ´Vchrom
Scyto ´Vcyto ´ Schrom ´Vchrom
ð1Þ
where S is the ﬂuorescence signal and V the average fraction of the volume
occupied by either chromosomes or cytoplasm. Vchrom (16%) was determined by
confocal microscopy on 32 E14 cells. Brieﬂy, an E14 cell line expressing an H2B-
mCherry and a cytoplasmic YFP was seeded in Fluorodishes coated with 5 ng µl−1
recombinant mouse E-cadherin Fc chimera protein (R&D systems, #748-EC-050)
at a density of 120,000 cells cm−2 and ﬁxed after 24 h. Mitotic cells were images in
3D stacks on the LSM700 with z steps of 0.496 µm (otherwise same imaging
settings as for the NIH-3T3 imaging). The 3D segmentation of the chromosomes
and cytoplasm was done using a pipeline developed by the bioimaging core facility
of EPFL on the Imaris software (Bitplane). Vcyto was determined by 1-Vchrom
(84%). For NIH-3T3, volumes measured for E14 cells were used as a proxy. The
MBF was averaged over >10 cells per clone for 94% of the TFs and over 4 to 9 cells
for 6% (n= 29) of the TFs in E14 cell lines, and over 17 of the 20 NIH-3T3 cell
lines, while the 3 others where averaged over 4 to 6 cells. For Supplementary
Fig. 1g, Supplementary Data 2 from Ginno et al. was downloaded and data for
genes present in that study and for which we measured a MBF was merged based
on gene name. Mitotic enrichment data was calculated as the log of the mean
Chromatome reporter signal in M-phase plus one, divided by the mean Proteome
reporter signal in M-phase plus one. For Supplementary Fig. 1h, TFs endogenously
expressed in NIH-3T3 were deﬁned as ln (average expression) >2 based on
expression data from54 (GSE66243) and TFs endogenously expressed in ES cells
were deﬁned as ln (average E14 2i 72 h expression) >0 based on expression data
from67 (GSE77420).
To compare the MBF between endogenous and exogenous expression of SOX2-
SNAP, the cell lines were labeled with 24 nM of the SNAP-Cell_647-SiR dye (New
England BioLabs Cat# S9102S) and imaged on the In Cell Analyzer with the Cy5
channel (Supplementary Fig. 1b). MBF were measured manually as described above
for NIH-3T3. To compare the MBF between wild type TFs and TFs tagged with 5
arginine residues (Supplementary Fig. 1k), cells were imaged as described above for
the large scale quantiﬁcation. MBF were measured manually as described above for
NIH-3T3 cells.
Immunoﬂuorescence. Cells were ﬁxed for 30 min with 2% PFA in PBS, per-
meabilized in 0.5% Triton in PBS, and blocked with PBS and 1% BSA for 30–60
min Samples were incubated with primary antibodies, either anti-HA (anti-HA.11
IgG, BioLegend, # 901501) at 1:500 dilution or anti H3K9me3 (Abcam, #ab8898),
at 1:200 dilution in PBS and 1% BSA overnight at 4 °C. Samples were washed twice
in PBS. For anti-HA immunostainings, samples were then incubated with either an
anti-mouse Alexa 488 antibody (Life Technologies, cat # A21202) or an anti-mouse
Alexa 647 antibody (Life Technologies, cat # A-31571) for the OCT4-HA/YPet-
Sox2 co-expression experiment (Supplementary Fig.4e). For the anti-H3K9me3
immunostaining, samples were incubated with an anti-rabbit Alexa 647 antibody
(Life Technologies, cat # A-31573). All secondary antibodies were used at 1:1000
dilution in PBS and 1% BSA, and left on samples for 45–60 min followed by three
washes with 0.1% PBS-Tween, incubation with 2 ng ml−1 DAPI, three washes with
PBS and 0.1% Tween, and two washes with PBS.
DNA-binding domain assignment and machine learning analysis. The number
of DNA binding domains per TF and their family were extracted from the UniProt
database. The DBD families (classiﬁed as described on http://www.edgar-
wingender.de/muTF_classiﬁcation-1.html, based on ref. 68) were included in the
analysis if present on more than 10 TFs for which we obtained a MBF. TFs with
more than one DBD type were included to each of the DBD families. Therefore, in
Fig. 1c, some TFs are represented in several boxes. Amino acids were classiﬁed as in
Lee et al., 2009, into the following categories: positively charged, aromatic, polar,
hydrophobic aliphatic, tiny, bulky, and small amino acids (see Supplementary
Table 4). Additionally, parameters including the sum of the amino acid grand
average of hydropaticity (GRAVY) score of the protein, the total number of con-
secutive positive amino acids, the total number of consecutive neutral amino acids
and the total number of consecutive negative amino acids were calculated as
previously described69. Most sequence-based parameters were extracted using protr
package in R70. The sum and the fraction of disordered domains (>5 disordered
amino acids in a row) were evaluated using ANCHOR online tool71. The disper-
sion of positive charges was calculated using a sliding window of 5 amino acids to
sum the number of arginine and lysine residues and quantiﬁed as the variance over
the mean of those sums. All absolute counts of amino acids were normalized
between 0 and 1. Absence or presence of DBD was annotated with 0 and 1,
respectively, for each TF. TFs with missing variables were removed from the
analysis. The coefﬁcient for each parameter was calculated using a lasso regularized
generalized linear model from glmnet package on R45 on the log of the MBF, and
averaged over all the runs. Signiﬁcant parameters are described as parameters
retained by the model in 90% of the runs (n= 500).
Imaging and co-localization analysis in NIH-3T3 cells. NIH-3T3 cells (kindly
provided by the laboratory of Ueli Schibler, University of Geneva) were seeded in
FluoroDishes (WPI, FD35–100) at densities of 36,000 cells cm−2 24 h before
imaging and treated with 500 ng ml−1 of doxycycline. Shortly before imaging, cells
were incubated with 1.62 μM of Hoechst 33342 (Invitrogen, #H3570) for 15 min
and washed twice with PBS.
Cells were imaged using a confocal microscope (ZEISS LSM 700 INVERT) with
a ×63 objective at 37 °C and 5% CO2. Channel settings were as following: EYFP
2.4% laser power, 700–900 gain, 41.1 μM pinhole; H342 2.6% laser power, 500–700
gain, 39 μM pinhole. Image dimensions: 50.8 × 50.8 μm, 0.05 μm pixel−1.
Whole cell signal co-localization was performed by pixel-pixel correlation of the
Hoechst and YPet signal images using the R software. Brieﬂy, the Hoechst and YPet
images were converted into text images and the correlation score between the two
channels was calculated for each cell, using 10 cells per cell line.
The co-localization in different DNA regions was analyzed using an automated
image segmentation pipeline in FIJI. Brieﬂy, nuclei were identiﬁed and segmented
based on the Hoechst signal and 3 regions with high, medium and low Hoechst
levels within each nucleus were deﬁned by k-means clustering. Subsequently, the
corresponding YPet signal in each of the 3 regions was measured. Ten cells were
analyzed per cell line.
Fluorescence recovery after photobleaching (FRAP). E14 cells (kindly provided
by the laboratory of Didier Trono, EPFL) were seeded in Fluorodishes coated with
5 ng µl−1 recombinant mouse or rat E-cadherin Fc chimera protein (R&D systems,
#748-EC-050 and #8144-EC-050 respectively) at densities of 120,000 cells cm−2 24
h before imaging and induced with 500 ng ml−1 doxycycline.
Cells were imaged using a confocal microscope (ZEISS LSM 700 INVERT) with
a ×63 objective at 37 °C and 5% CO2. Channel settings: EYFP 2.4% laser power,
700–900 gain, 46.2 µm pinhole. Image dimensions: 200 × 200 pixels (19.85 × 19.85
µm).
To image ﬂuorescence recovery after photobleaching, a circular region of
interest (ROI) with a diameter of 20 pixels on chromosomes of metaphase cells was
selected for bleaching. In addition, two circular control ROIs of the same size were
selected, one on the mitotic chromosomes to be used as a non-bleached control and
one next to the cell to control for ﬂuctuations of background ﬂuorescence. Cells
were ﬁrst imaged ﬁve times with time intervals of 0.38 s to obtain pre-bleach
intensity values, and subsequently the selected ROI was bleached for 0.6 s (ﬁve
iterations) at 100% laser power. Fluorescence recovery was then imaged for 74 s at
intervals of 0.38 s.
The same FRAP experiments were performed in interphase cells (one bleached
ROI and one non-bleached control ROI within the nucleus, plus one background
ROI next to the cell of interest).
To analyze the recovery time, the mean intensities of the bleached ROI and the
two non-bleached control ROIs were measured in all time frames. As mitotic
chromosomes tended to move throughout the acquisition, the ROIs on mitotic
chromosomes were adjusted manually. The recovery curve of the bleached ROI was
normalized based on the intensity values before bleaching and on the two control
ROIs. The t1/2 recovery time was calculated using easyFRAP2mac72 and averaged
over 10 mitotic and 10 interphase cells. To analyze the FRAP data, the intensity was
normalized as:
I tð Þ ¼
1
npre
Pnpre
t¼1 IðtÞROI2′
IðtÞROI2′
0
@
1
A  IðtÞROI1′
1
npre
Pnpre
t¼1 IðtÞROI1′
0
@
1
A ð2Þ
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Where npre is the number of pre-bleached frames, I(t)ROI1’ is the intensity of the
bleached spot minus background and I(t)ROI2’ is the intensity of the non-bleached
control minus background.
The ﬁt is calculated for each cell as:
Ifit1 ¼ I0  a ´ eβ´ t ð3Þ
The immobile fraction (Imof) and t1/2 are calculated for each cell as:
Imof ¼ 1 a
1 ðI0  aÞ
 
ð4Þ
t1=2 ¼
lnð2Þ
β
ð5Þ
ChIP-seq. E14 and NIH-3T3 cells were treated overnight with 500 ng ml−1 of
Doxycycline one day after seeding. Brieﬂy, at least 107 cells were ﬁxed in 1%
formaldehyde for 10 min at room temperature, quenched with 250 mM Tris-HCl
pH 8.0, washed with PBS, spun down, and stored at −80 °C. The cell pellet was
resuspended in 1.5 ml LB1 (50 mM HEPES-KOH pH 7.4, 140 mM NaCl, 1 mM
EDTA, 0.5 mM EGTA, 10% Glycerol, 0.5% NP40, 0.25% TritonX-100), incubated
10 min at 4 °C, spun down, and resuspended in 1.5 ml LB2 (10 mM Tris-HCl pH
8.0, 200 mM NaCl, 1 mM EDTA, 0.5 mM EGTA), and incubated 10 min at 4 °C.
The pellet was spun down and rinsed twice with SDS shearing buffer (10 mM Tris-
HCl pH 8.0, 1 mM EDTA, 0.15% SDS), and ﬁnally resuspended in 0.9 ml SDS
shearing buffer. All buffers contain 1:100 diluted Protease Inhibitor Cocktail in
DMSO (Sigma). The suspension was transferred to a milliTUBE 1 ml AFA ﬁber
and sonicated on a E220 focused ultrasonicator (Covaris) using the following
settings: 20 min, 200 cycles, 5% duty, 140W, and input sample aliquots were taken.
Sonicated chromatin was incubated with 500 ng of the anti-HA.11 antibody
(BioLegend, # 901501) per 106 cells at 4 °C overnight. Protein G Dynabeads
(Thermo Fischer) were added to the chromatin and incubated for 3 h at 4 °C. The
chromatin was washed several times at 4 °C with 5 min incubation between each
wash and 2 min magnetization to collect beads; twice with Low Salt Wash Buffer
(10 mM Tris-HCl pH 8.0, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.15%
SDS, 1 mM PMSF), once with High Salt Wash Buffer (10 mM Tris-HCl pH 8.0,
500 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.15% SDS, 1 mM PMSF), once
with LiCl Wash Buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA, 0.5 mM EGTA,
250 mM LiCl, 1% NP40, 1% sodium deoxycholate, 1 mM PMSF), and ﬁnally with
TE buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA, 1 mM PMSF). Beads were ﬁnally
resuspended in Elution buffer (TE buffer with 1% SDS and 150 mM NaCl), treated
with 400 ng/ml Proteinase K and reverse crosslinked at 65 °C 1100 rpm overnight.
Input samples were treated with 100 mg/ml RNase A and 400 ng ml−1 Proteinase
K and reverse crosslinked at 65 °C 1100 rpm overnight. Samples were puriﬁed
using Qiagen MinElute PCR puriﬁcation kit. Libraries were prepared with NEB-
Next ChIP-seq Library Prep Master Mix Set (NEB, #E6040) using insert size
selection of 250 bp. Sequencing was performed using 37 nt paired-end reads on an
Illumina NextSeq 500. Reads were aligned to the mouse reference genome mm10
using STAR73 with settings ‘--alignMatesGapMax 2000 --alignIntronMax 1
--alignEndsType EndtoEnd -- outFilterMultimapNmax 1’. Duplicate reads were
removed with Picard (Broad Institute) and reads not mapping to chromosomes
1–19, X, or Y were removed. For each sample, peaks were called with MACS274
with settings ‘-f BAMPE -g mm’ (and ‘-q 0.01’ for Supplementary Fig. 4a). Peaks
overlapping peaks called for input (non-immunoprecipitated chromatin) from
NIH-3T3 cells and ENCODE blacklisted peaks were discarded75. Downsampling of
reads (Supplementary Fig. 4c) was done using SAMtools76. For HOMER peak
calling (Supplementary Fig. 4b), the function ﬁndPeaks was used with settings
‘-style factor’ and using Input chromatin as background (for Supplementary
Fig. 4b, 1 was added to the number of HOMER-called peaks to avoid zeros). The
HOMER277 function annotatePeaks.pl was used with settings ‘-noadj -len 0 -size
given’ to count the number of reads in peaks and divided by total aligned reads for
each sample to get the fraction of reads in peaks. Motif ﬁnding was done using the
HOMER2 function ﬁndMotifsGenome.pl with settings ‘-size given’. Top motifs
were selected as the most signiﬁcant de novo hit in either the entire peak set for
each factor, or in the peaks overlapping (open) or not overlapping (closed) open
chromatin based on ATAC-seq peaks in NIH-3T3 (see Supplementary Table 9).
Published motifs were selected by taking the most enriched motif that corre-
sponded to each factor or its TF family (from either de novo or known motif
search) (see Supplementary Table 9). For those factors where no published motif
was enriched, JASPAR-annotated motifs were used where possible (DLX1, DLX6,
HLF, SIX6, and TEAD1)78. In the ﬁnal analysis, only those motifs with a p-value
lower than 0.05 were kept, and factors with top motifs corresponding to SeqBias
were discarded. The HOMER2 function scanMotifGenomeWide.pl was used to
calculate the occurrence of motifs. For Fig. 4a-b, the average number of ChIP-seq
peaks were used for duplicated factors (BHLHB8, FOXA1, SOX2). bigWig ﬁles
were generated by the deepTools function bamCoverage (with setting ‘--normal-
izeUsingRPKM’). Genome tracks were visualized in the UCSC genome browser.
ATAC-seq. NIH-3T3 cells were plated and treated with 500 ng ml−1 of Doxycy-
cline 48 h before the experiment. ATAC-seq experiments were performed using in-
house prepared Tn5 transposase (in-house production79). Brieﬂy, 5*104 cells were
pelleted and washed with 1× ice cold PBS at 800×g for 5 min Cells were resus-
pended in 50 μl of ice-cold ATAC lysis buffer (10 mM Tris-HCl pH 7.4, 10 mM
NaCl, 3 mM MgCl2, 0.1% NP40), and pelleted at 800×g for 10 min at 4 °C. Cells
were subsequently resuspended in 50 μl of transposition reaction mix containing
0.5 μM of Tn5 transposase in TAPS-DMF buffer (10 mM TAPS-NaOH, 5 mM
Mgcl2, 10% DMF) and incubated at 37 °C for 30 min The transposed DNA was
puriﬁed using a DNA puriﬁcation kit (Zymo Research #D4003) and eluted in 12 μl
of water. A 65 μl PCR reaction was setup with 10 μl of transposed DNA, 0.5 μM of
forward primer Ad1_noMX, 0.5 μM of multiplexing reverse primer Ad2.x80, 0.6x
SYBR® Green I, and 1× PCR Master Mix (NEB #M0544). The samples were
thermocycled at 72 °C for 5 min, 98 °C for 30 s, followed by 5 cycles at 98 °C for
10 s, 63 °C for 30 s and 72 °C for 1 min A 15 μl aliquot was analyzed by qPCR to
determine the number of additional cycles needed to avoid ampliﬁcation satura-
tion. The ampliﬁed ATAC libraries were puriﬁed using a DNA puriﬁcation kit
(Zymo Research #D4003) and size selected using Agencourt AMPure beads (0.55×
unbound fraction followed by 1.2× bound fraction). All libraries were sequenced
with 75-nucleotide read length paired-end sequencing on a Illumina NextSeq 500
with 30–60 million reads being sequenced for each sample.
Two replicates were performed for each TF overexpression sample, and four
replicates for control cells expressing only rtTA3G. Sequencing and read alignment
was performed as described above for ChIP-seq. To determine regions that were
accessible in the NIH-3T3 genome, we performed one ATAC-seq replicate of the
parental NIH-3T3 cell line and called peaks as described above for ChIP-seq. ChIP-
seq peaks from all TFs analyzed and ATAC-seq peaks from all samples were
merged using BEDTools81 into two separate ﬁles and the number of ATAC-seq
reads in these peak sets was calculated for each sample using HOMER2 as
described above for ChIP-seq. Read counts were normalized with edgeR82 using
TMM. The limma83 package was used to call regions that had differentially
abundant ATAC-seq reads between the TF overexpression condition and control
cells expressing only rtTA3G, with an adjusted p-value of 0.05 as cutoff. For plots
displayed in log scale, 1 was added to the number of regions with affected
accessibility for each TF. Note that the number of TF peaks used in the ATAC-seq
data represents the number of merged peaks for ChIP-seq duplicated factors.
bigWig ﬁles were generated by merging replicate bam ﬁles with SAMtools followed
by the deepTools functions bamCoverage (with setting ‘--normalizeUsingRPKM’).
log2-ratio bigWig ﬁles were generated using the deepTools function bamCompare
based on merged replicates for each TF overexpression sample over merged
replicates for control (rtTA3G). Heatmaps were generated using deepTools
computeMatrix (with setting ‘reference-point’) and plotHeatmap centered around
the merged peak set for each TF.
Single molecule ﬂuorescence microscopy. Cells were seeded on glass-bottom
dishes (Delta T culture dishes, Bioptechs, Pennsylvania, USA) one day before the
measurement. To induce the expression of Halo-tagged TFs, 10 ng ml−1 doxycy-
cline was added 4 h after seeding the cells. Before imaging, Halo-tagged TFs were
labeled with ﬂuorescent SiR ligand (kindly provided by Kai Johnsson, EPFL,
Switzerland, (Promega, #G8251)) according to the HaloTag protocol (Promega).
DNA was labeled with 0.3 µg ml−1 Hoechst 33342 (ThermoFisher, #62249). Single
molecule imaging was performed in phenol free Opti-MEM (ThermoFisher,
#11058021) at 37 °C for up to 120 min
Single molecule microscopy was performed on a custom built microscope
described previously84. Brieﬂy, light of a 405 nm laser (Laser MLD, 200 mW,
Cobolt, Solna, Sweden) and a 638 nm laser (IBEAM-SMART-640-S, 150 mW,
Toptica, Gräfelﬁng, Germany) were collimated, combined using a dichroic mirror,
controlled by an AOTF (AOTFnC-400.650-TN, AA Optoelectronics, Orsay,
France) and used for inclined illumination in a ﬂuorescence microscope (TiE,
Nikon, Tokyo, Japan) with a high-NA objective (100×, NA 1.45, Nikon, Tokyo,
Japan). Fluorescent light was ﬁltered by a multiband emission ﬁlter (F72–866,
AHF, Tübingen, Germany) and detected by an EMCCD camera (iXon Ultra DU
897U, Andor, Belfast, UK).
To investigate binding properties of TFs, we used two different illumination
schemes: (i) continuous movies of cells illuminated with the 638 nm laser to excite
SiR were recorded with 50 ms camera integration time, preceded and followed by a
snapshot of cells illuminated with the 405 nm laser to excite Hoechst 33342 (50 ms
integration time). (ii) movies were recorded in which snapshots of cells illuminated
for 50 ms with the 638 nm laser were alternated every 550 ms with snapshots of
cells illuminated for 50 ms with the 405 nm laser (1.2 s total cycle time).
We detected Halo-TF molecules based on their ﬂuorescence intensity above the
background level and determined their position using a 2D Gaussian ﬁt84. Halo-TF
molecules were identiﬁed as bound to chromatin when they were detected within a
spherical region of 160 nm of diameter for 2 consecutive frames (i.e., for at least
100 ms in illumination scheme (i) and for at least 1.2 s in illumination scheme (ii)).
We separated chromosomal regions into three classes, bright, intermediate, and
dark, according to their Hoechst 33342 intensity by means of two user deﬁned
intensity thresholds. Subsequent analysis steps were performed separately for each
intensity class. We assigned bound molecules to a chromosomal region by
comparing their position of ﬁrst appearance with the preceding Hoechst image.
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This allowed accounting for cellular movements during long acquisition times in
illumination scheme (ii).
We determined the fraction of bound TF-Halo molecules per area by dividing
the number of molecules identiﬁed as bound in illumination scheme (i), Nbi, by the
area Aa of the respective Hoechst intensity class, a= bright, intermediate or dark.
We then divided the result by the total number of detected Halo-TF molecules,
Ntot, and the video capture time T. The result is a measure of binding frequency,
which we referred to as pseudo on-rate (ψon-rate):
ψoni ¼
Nbi
AaNtotT
ð6Þ
The ψon-rate of long bound Halo-TF molecules was determined analogously
using the respective molecule counts of illumination scheme ii):
ψonii ¼
Nbii
AaNtotT
ð7Þ
To obtain a simple measure for the residence time τres of speciﬁcally bound
molecules, we calculated the average time that Halo-TF molecules spent bound in
illumination scheme (ii):
τres ¼
1
Ntot
XNtot
j¼1
tbii;j ð8Þ
where tbii,j is the binding time of molecule j in illumination scheme (ii).
We then ordered the TFs with respect to this measure.
Quantiﬁcation and statistical analysis. Statistical analyses of violin plots of TF
distributions (Fig. 1e), on the MBF for NLS mutants (Supplementary Fig. 1j) and
on the MBF for TFs tagged with ﬁve arginine residues (Supplementary Fig. 1k)
were performed using Wilcoxon rank-sum test. For plots with linear scales, r-
values and p-values are based on Pearson correlation (Figs. 2d-g, 3c-k, 4a-b, 5a, 5d-
e, and Supplementary Figs. 1a, 1d, 1f, 2a-b, 3d-f). For plots displayed in log scale,
Rho-values and p-values are based on Spearman’s rank correlation (Figs. 4d-e, 5c,
Supplementary Figures 4a-d, 4h-j, 5a and 5c-g). Note that correlations were cal-
culated using averages for replicates. Duplicate values were not averaged for the
FOM of top motifs due to enrichment for different motifs.
Code availability. The code to analyze residence times and pseudo-on-rates from
single molecule tracks is available as Matlab script on the Dryad Data Repository
(https://doi.org/10.5061/dryad.9pc7458). Other codes used in this study are avail-
able from the corresponding author upon reasonable request.
Reporting summary. Further information on experimental design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Data supporting the ﬁndings of this manuscript are available from the corre-
sponding author upon reasonable request. A reporting summary for this Article is
available as a Supplementary Information ﬁle. ChIP-seq and ATAC-seq data that
support the ﬁndings of this study have been deposited in GEO (Gene Expression
Omnibus) with the accession code GSE119784.
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